1 unknown, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Flavin Mononucleotide: new trials by email Literature Review of Flavin Mononucleotide trials Research Report on Flavin Mononucleotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection - Crohn's Disease, Oral Ulcer | Phase 3 | Withdrawn | Xijing Hospital of Digestive Diseases | 2016-03-01 | 2023-02-01 | |
| Treatment of Keratoconus Using Collagen Cross-Linking Riboflavin-5-phosphate, Sham cross-linking - Keratoconus | Phase 2 / Phase 3 | Unknown | University at Buffalo | 150 | 2008-09-01 | 2009-02-11 |
Corneal Diseases (1) · Crohn Disease (1) · Dilatation, Pathologic (1) · Keratoconus (1) · Oral Ulcer (1)
University at Buffalo (1) · Xijing Hospital of Digestive Diseases (1)
China (1) · United States (1)
James J Reidy, M.D. (1) · Ying Han, Ph. D (1)
PMID 12719068, PMID 16565005, PMID 16765803, PMID 16900027, PMID 16952090, PMID 17457183, PMID 17457184, PMID 17531694, PMID 17720054